United Therapeutics Corp (NASDAQ:UTHR)

124.66
Data as of Oct 17
 +0.28 / +0.23%
Today’s Change
80.51
Today|||52-Week Range
136.93
+10.24%
Year-to-Date

Stock Price Forecast

The 14 analysts offering 12-month price forecasts for United Therapeutics Corp have a median target of 105.00, with a high estimate of 165.00 and a low estimate of 79.00. The median estimate represents a -15.77% decrease from the last price of 124.66.

Analyst Recommendations

The current consensus among 15 polled investment analysts is to Buy stock in United Therapeutics Corp. This rating has held steady since October, when it was upgraded from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$1.90
Sales
$335.1M
Reporting Date
Oct 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -9.33%
 
 
 
 
 
 
Growthannually 157.69%
 
 
 
 
 
 

Sales

Growthquarterly 3.80%
 
 
 
 
 
 
Growthannually 15.49%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.